SAM
TGTX icon

Simplify Asset Management’s TG Therapeutics TGTX Stock Holding History

Simplify Asset Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Buy
21,269
+5,220
+33% +$214K 0.02% 78
2026
Q1 		$533K Sell
16,049
-7,184
-31% -$214K 0.01% 101
2025
Q4 		$693K Buy
23,233
+10,736
+86% +$351K 0.01% 95
2025
Q3 		$451K Buy
12,497
+2,293
+22% +$75.5K 0.01% 104
2025
Q2 		$367K Sell
10,204
-1,084
-10% -$40.4K 0.02% 82
2025
Q1 		$445K Buy
11,288
+51
+0.5% +$1.72K 0.02% 83
2024
Q4 		$338K Buy
+11,237
New +$322K 0.02% 84

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Simplify Asset Management's TGTX Position: Q2 2026 in Review

Simplify Asset Management increased its TG Therapeutics (TGTX) stake by 33% in Q2 2026, buying an estimated $214K and bringing the position to 21,269 shares worth $1.17M. The position accounts for 0.02% of the portfolio, ranked #78.

Simplify Asset Management first reported a position in TGTX in Q4 2024 and has held it in 7 quarters since. 194 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Simplify Asset Management held 21,269 shares of TG Therapeutics worth $1.17M as of Q2 2026.
  • Simplify Asset Management bought 5,220 TG Therapeutics shares in Q2 2026, an estimated $214K.
  • TG Therapeutics made up 0.02% of Simplify Asset Management's portfolio in Q2 2026, its #78 holding.
  • Simplify Asset Management first reported a position in TG Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 194 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.